| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40541f6aa62bd2469923b5eeff36754b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032 |
| filingDate |
2018-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b818166170845c9416499ea066690246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e77a4a2438d27cb197600d00b99b9d90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fcd478e792596487492d88c07d2ea0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e379d92ddb65ba260ea6a86cc9f7185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_636fd8d9f2d81008be289c2e53a5b979 |
| publicationDate |
2019-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109294980-A |
| titleOfInvention |
Application of salidroside and salidroside in directed differentiation of stem cells into cardiomyocyte-like cells |
| abstract |
The invention provides the application of salidroside and salidroside in inducing the directional differentiation of stem cells into cardiomyocyte-like cells, especially the combination of salidroside and hypoxia as an inducer for inducing the directional differentiation of adipose mesenchymal stem cells into cardiac muscle like cells. The invention develops a new application of salidroside, namely inducing the directional differentiation of adipose stem cells and other stem cells into cardiomyocyte-like cells in vitro; and provides the role of salidroside and salidroside in inducing the directional differentiation of adult stem cells into cardiomyocyte-like cells, It is conducive to in-depth research in the field of in vivo stem cell transplantation in the treatment of acute and chronic myocardial injury and cardiovascular diseases, and provides a basis for the development of new drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115607558-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113133500-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113133500-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116083352-A |
| priorityDate |
2018-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |